Meet the Arvita Team
Javier Alfaro
Co-Founder
Dr. Javier Antonio Alfaro brings a wealth of experience in developing mRNA-based therapies and vaccines, with a research focus on integrating multi-omic analysis and artificial intelligence to design personalized treatments for complex diseases.
Currently, Javier is Canada Research Chair for precision Immunotherapy at the University of Calgary, with a research focus on mRNA therapeutics in cancer and infectious disease. His previous work as an independent researcher at institutions such as the Universities of Edinburgh (UK) , The International Cancer Vaccine Science Centre (Poland) and Victoria (Canada) has driven advancements in cancer immunotherapy and precision medicine. At Arvita Therapeutics, Dr. Alfaro will spearhead efforts to develop groundbreaking therapies for hereditary diseases like NF1 and pediatric and adult tumors.
Rajiv Khaneja
Co-Founder
Rajiv Khaneja has a long history of leading successful tech ventures. A serial entrepreneur, he launched his first company at the age of 17 with the first online polling platform. He later founded AdButler, a digital ad management service that scaled to manage billions of ads.
Building on these early successes, Rajiv expanded into investing with the creation of DoubleBlind, an investment and holding company. He brings with him a deep understanding of how to implement data solutions at scale and an appetite to join the tech-bio ecosystem, where biotechnology and laboratory automation intersect with advancements in data science and AI.
Today, Rajiv focuses on healthcare, specifically developing therapies for NF1 and pediatric tumors, aiming to improve the lives of children facing serious medical challenges.
Elizabeth Khaneja
Co-Founder
